10-K Filing

AXOGEN, INC. CIK: 805928 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001104659-15-017126`
Period End Date	20141231
Filing Date	20150305
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	axgn-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 30 Cash Flow Statement 58 Stockholders Equity 18

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$94.00K	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$58.00K	USD	Point-in-time
Common stock, Par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, Par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.22M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.07M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.91M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of approximately $94,000 and $58,000, respectively	`AccountsReceivableNetCurrent`	$1.89M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	17.34M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.49M	shares	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of approximately $94,000 and $58,000, respectively	`AccountsReceivableNetCurrent`	$2.87M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	17.34M	shares	Point-in-time
Inventory	`InventoryNet`	$3.40M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.49M	shares	Point-in-time
Inventory	`InventoryNet`	$3.21M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$109.37K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$296.72K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.41M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.66M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$381.69K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$619.03K	USD	Point-in-time
Intangible assets	`FiniteLivedIntangibleAssetsNet`	$570.40K	USD	Point-in-time
Intangible assets	`FiniteLivedIntangibleAssetsNet`	$577.17K	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$793.50K	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$1.07M	USD	Point-in-time
Total Assets	`Assets`	$16.40M	USD	Point-in-time
Total Assets	`Assets`	$27.68M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.08M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.43M	USD	Point-in-time
Current deferred Revenue	`DeferredRevenueCurrent`	$14.12K	USD	Point-in-time
Current deferred Revenue	`DeferredRevenueCurrent`	$14.12K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.45M	USD	Point-in-time
Note Payable	`LongTermNotesPayable`	$25.09M	USD	Point-in-time
Note Payable	`LongTermNotesPayable`	$25.36M	USD	Point-in-time
Long Term Deferred Revenue	`DeferredRevenueNoncurrent`	$85.88K	USD	Point-in-time
Long Term Deferred Revenue	`DeferredRevenueNoncurrent`	$115.38K	USD	Point-in-time
Total liabilities	`Liabilities`	$27.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$27.55M	USD	Point-in-time
Common stock, $.01 par value; 50,000,000 shares authorized; 19,488,814 and 17,339,561 shares issued and outstanding	`CommonStockValue`	$194.89K	USD	Point-in-time
Common stock, $.01 par value; 50,000,000 shares authorized; 19,488,814 and 17,339,561 shares issued and outstanding	`CommonStockValue`	$173.40K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$78.68M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$72.37M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-90.12M	USD	Point-in-time
Total shareholders' equity (deficit)	`StockholdersEquity`	$-2.83M	USD	Point-in-time
Total shareholders' equity (deficit)	`StockholdersEquity`	$-11.25M	USD	Point-in-time
Total shareholders' equity (deficit)	`StockholdersEquity`	$136.63K	USD	Point-in-time
Total Liabilities and Shareholders' equity	`LiabilitiesAndStockholdersEquity`	$27.68M	USD	Point-in-time
Total Liabilities and Shareholders' equity	`LiabilitiesAndStockholdersEquity`	$16.40M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$10.95M	USD	Annual
Revenues	`Revenues`	$16.82M	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$3.44M	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$2.44M	USD	Annual
Gross profit	`GrossProfit`	$8.51M	USD	Annual
Gross profit	`GrossProfit`	$13.38M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$13.19M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$10.26M	USD	Annual
Research and development costs	`ResearchAndDevelopmentExpense`	$3.03M	USD	Annual
Research and development costs	`ResearchAndDevelopmentExpense`	$2.13M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.72M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.95M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$23.18M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$18.10M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-9.59M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-9.80M	USD	Annual
Interest expense	`InterestExpense`	$6.81M	USD	Annual
Interest expense	`InterestExpense`	$4.82M	USD	Annual
Interest expense-deferred financing costs	`AmortizationOfFinancingCostsAndDiscounts`	$1.10M	USD	Annual
Interest expense-deferred financing costs	`AmortizationOfFinancingCostsAndDiscounts`	$178.86K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$3.15K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$33.89K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-4.96M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-7.91M	USD	Annual
Net Loss	`NetIncomeLoss`	$-14.56M	USD	Annual
Net Loss	`NetIncomeLoss`	$-17.71M	USD	Annual
Weighted Average Common Shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.72M	shares	Annual
Weighted Average Common Shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.50M	shares	Annual
Loss Per Common share - basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.08	USD	Annual
Loss Per Common share - basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.99	USD	Annual

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Proceeds from notes payable	`NotesIssued1`	$25.00M	USD	Annual
Net loss	`NetIncomeLoss`	$-14.56M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.71M	USD	Annual
Issuance of shares	`StockIssued1`	$3.55M	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$153.67K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$79.23K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$45.22K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$59.10K	USD	Annual
Loss on impairment	`ImpairmentOfIntangibleAssetsAndGoodwill`	$9.42K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$199.33K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$178.86K	USD	Annual
Write off of deferred financing costs	`WriteOffOfDeferredFinancingCosts`	$901.19K	USD	Annual
Provision for bad debt	`ProvisionForDoubtfulAccounts`	$58.62K	USD	Annual
Provision for bad debt	`ProvisionForDoubtfulAccounts`	$35.48K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$956.45K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$671.89K	USD	Annual
Stock grant for service	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$60.12K	USD	Annual
Interest added to note payable	`PaidInKindInterest`	$5.02M	USD	Annual
Interest added to note payable	`PaidInKindInterest`	$3.78M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.01M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$902.23K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$247.33K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-184.82K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-187.35K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$109.46K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$430.58K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$498.29K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$29.50K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$100.00K	USD	Annual
Net cash used for operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-10.44M	USD	Annual
Net cash used for operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-10.45M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$178.78K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$542.04K	USD	Annual
Acquisition of intangible assets	`PaymentsToAcquireIntangibleAssets`	$52.00K	USD	Annual
Acquisition of intangible assets	`PaymentsToAcquireIntangibleAssets`	$65.19K	USD	Annual
Net cash used for investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-243.97K	USD	Annual
Net cash used for investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-594.05K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.63M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$16.78M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.75M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$820.44K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$135.84K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$73.33K	USD	Annual
Net cash (used) / provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$16.85M	USD	Annual
Net cash (used) / provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-808.85K	USD	Annual
Net (decrease) / increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$6.16M	USD	Annual
Net (decrease) / increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-11.85M	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$8.22M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$20.07M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$13.91M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$8.22M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.07M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.91M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$3.91M	USD	Annual
Cash paid for interest	`InterestPaid`	$1.03M	USD	Annual
Payments of fixed assets in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$22.57K	USD	Annual
Payments of fixed assets in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$173.61K	USD	Annual
Payments of long term debt with proceeds from note payable of $25,000,000 and issuance of shares of $3,550,000	`NotesReduction`	$28.55M	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$-2.83M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-11.25M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$136.63K	USD	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	17.34M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	19.49M	shares	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$956.45K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$671.89K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.33K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$135.84K	USD	Annual
Issuance of common shares	`StockIssuedDuringPeriodValueNewIssues`	$5.24M	USD	Annual
Issuance of common shares	`StockIssuedDuringPeriodValueNewIssues`	$16.78M	USD	Annual
Net loss	`NetIncomeLoss`	$-14.56M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.71M	USD	Annual
Ending Balance	`StockholdersEquity`	$-2.83M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-11.25M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$136.63K	USD	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	17.34M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	19.49M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.